Beijing 302 Hospital
Clinical trials sponsored by Beijing 302 Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a cancer drug help cure hepatitis b? new trial launches Results expected Oct 2026 (estimated)
- Can a daily pill help breast cancer that outsmarts two antibody drugs? Results expected Dec 2026 (estimated)
- Shock therapy? no, just a gentle tingle to ease ERCP sedation risks Results expected Aug 2027 (estimated)
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control CompletedThis early-phase trial tested two oral drugs, dalpiciclib and chidamide, in 22 people with HR+/HER2- advanced breast cancer whose disease had worsened after CDK4/6 inhibitor therapy. The main goal was to find the safest dose. Researchers also looked at how well the combination sh…
Phase 1 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a gentle electric zap at key points make emergency gut exams easier for liver patients?
Symptom relief CompletedThis study tested whether a mild electrical stimulation at specific acupoints (TEAS) helps people with cirrhosis tolerate an urgent endoscopy for suspected variceal bleeding. 180 patients were split into three groups: active TEAS, sham TEAS (electrodes but no current), or standar…
Sponsor: Beijing 302 Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC